Despite reports showing that IRF4 plays an oncogenic role in promoting lymphomagenesis via downregulation of BCL2 family proteins, such as BIM and BMF,41 we revealed that IRF4 directly interacts with BCL2 in DLBCL. This evidence concerns the gene IRF4 and diffuse large B-cell lymphoma.